What is she best known for?
The fields of study she is best known for:
Her scientific interests lie mostly in Immunology, Virology, Virus, Hepatitis C virus and Hepatitis C.
Her work in Immune system, Antibody, CTL*, Hepatitis B virus and Antigen is related to Immunology.
Her work deals with themes such as Epitope, Cytotoxic T cell, Chronic liver disease and T cell, which intersect with Virology.
Her studies in Virus integrate themes in fields like Microbiome, Plant disease resistance, Host, Laboratory mouse and Memory T cell.
Her biological study deals with issues like Cirrhosis, which deal with fields such as Pathogenesis, Viral disease, Transmission, Liver cancer and Disease.
Her work carried out in the field of Hepatitis C brings together such families of science as RNA, Liver disease, Hepatitis A and Hepacivirus.
Her most cited work include:
- Immunology of hepatitis B virus and hepatitis C virus infection. (1313 citations)
- The liver as an immunological organ (802 citations)
- Pathogenesis, natural history, treatment, and prevention of hepatitis C. (784 citations)
What are the main themes of her work throughout her whole career to date?
Barbara Rehermann focuses on Immunology, Virology, Hepatitis C virus, Immune system and Virus.
Her study in Hepatitis B virus, Interferon, Antigen, Antibody and Hepatitis B is done as part of Immunology.
Her Hepatitis B virus study combines topics in areas such as Viral hepatitis and Chronic liver disease.
Barbara Rehermann interconnects T cell, CTL*, Cytotoxic T cell, CD8 and Epitope in the investigation of issues within Virology.
Her Hepatitis C virus study integrates concerns from other disciplines, such as RNA, Viremia and Hepatitis C.
Her Hepatitis C research incorporates elements of Cirrhosis, Viral load, Hepatitis, Liver disease and Seroconversion.
She most often published in these fields:
- Immunology (65.05%)
- Virology (56.99%)
- Hepatitis C virus (42.47%)
What were the highlights of her more recent work (between 2013-2021)?
- Immunology (65.05%)
- Hepatitis C virus (42.47%)
- Virology (56.99%)
In recent papers she was focusing on the following fields of study:
Her main research concerns Immunology, Hepatitis C virus, Virology, Immune system and Interferon.
As part of her studies on Immunology, Barbara Rehermann often connects relevant subjects like Liver disease.
Her Hepatitis C virus research includes themes of Peripheral blood mononuclear cell, Hepatitis C and Genotype.
Her Virology research is multidisciplinary, incorporating elements of Treatment regimen and Interleukin-7 receptor.
She works mostly in the field of Immune system, limiting it down to concerns involving Effector and, occasionally, Lymphatic system, Toxoplasma gondii, Senescence, T lymphocyte and Toxoplasmosis.
Barbara Rehermann combines subjects such as Cytotoxic T cell, Interleukin 12, Interleukin 21 and Cancer research with her study of Interferon.
Between 2013 and 2021, her most popular works were:
- Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance. (281 citations)
- Immune Responses to HCV and Other Hepatitis Viruses (190 citations)
- Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function (168 citations)
In her most recent research, the most cited papers focused on:
Her primary areas of investigation include Immunology, Immune system, Hepatitis C virus, Interferon and Immunity.
She combines topics linked to Virology with her work on Immunology.
Her research in Virology intersects with topics in Interleukin 12 and Interleukin 21.
Her Immune system research is multidisciplinary, relying on both Pegylated interferon, Peripheral blood mononuclear cell and Cytokine.
Her Hepatitis C virus study deals with Hepatitis C intersecting with Hepatitis A, Viral Vaccine, Gastroenterology and Liver biopsy.
Her Immunity research incorporates themes from Gastrointestinal Microbiome, HBsAg, Liver disease, Mycobiome and Human virome.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
